324 related articles for article (PubMed ID: 31682266)
1. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
[TBL] [Abstract][Full Text] [Related]
2. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
3. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R
J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179
[TBL] [Abstract][Full Text] [Related]
5. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
[TBL] [Abstract][Full Text] [Related]
6. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
[TBL] [Abstract][Full Text] [Related]
10. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
11. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
12. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
13. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
14. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products.
Zamarripa CA; Tilton HE; Lin S; Cone EJ; Winecker RE; Flegel RR; Kuntz D; Beals M; Jacques M; Clark M; Welsh ER; Wagner L; Bonn-Miller MO; Vandrey R; Spindle TR
J Anal Toxicol; 2024 Mar; 48(2):81-98. PubMed ID: 38217086
[TBL] [Abstract][Full Text] [Related]
16. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
17. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
[TBL] [Abstract][Full Text] [Related]
18. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
Pacifici R; Pichini S; Pellegrini M; Tittarelli R; Pantano F; Mannocchi G; Rotolo MC; Busardò FP
Clin Chem Lab Med; 2018 Dec; 57(2):238-243. PubMed ID: 30332386
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
Milman G; Schwope DM; Gorelick DA; Huestis MA
Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
[TBL] [Abstract][Full Text] [Related]
20. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
